Nature Reviews Nephrology

Article	Citations
A UMOD variant with intermediate effects	991
Mentorship in the lives of scholars	958
Inhibitory effects of oestradiol on ferroptosis may underlie sex differences in AKI	576
The changing landscape of kidney health and disease in Africa	545
Designing acute kidney injury clinical trials	534
Endoplasmic reticulum-mediated organelle crosstalk in kidney disease	469
Treatment of chronic kidney disease in older populations	432
Disaster preparedness for patients with kidney disease	381
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	357
Uropathogen and host responses in pyelonephritis	328
Urine as a source of biomarkers and biological knowledge in chronic kidney disease	293
Engineered CAR macrophages target kidney inflammation	277
Vaccination in patients with kidney failure: lessons from COVID-19	262
The GLP-1 receptor agonist revolution comes to nephrology	260
Role of the gut microbiota in the pathogenesis of IgA nephropathy	242
Making advance care planning easier for adults with kidney disease and their clinicians	236
CD93 and endothelial cells as therapeutic targets in podocytopathies	224
Kidney health within the broader non-communicable disease agenda	204
A single-cell atlas of DKD treatment responses	203
Genetic determinants of urine and plasma metabolite levels	196
GWAS scorecard prioritizes kidney genes using coding and regulatory variants	189
Consideration of sex differences is necessary to achieve health equity	185
Strategic rebalancing of kidney-related investments is key to implementing the WHO kidney health resolution	169
Roles of sensory receptors in non-sensory organs: the kidney and beyond	165
Beyond state borders: transforming dialysis care for undocumented immigrants	163

Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	161
The continued odyssey to unravel the secrets of kidney inflammation	157
Complosome — the intracellular complement system	144
Phosphate sensing via PTC glycolysis	134
Bringing Pride to nephrology	133
Reducing preventable acute kidney injury in a hospital setting	124
Mutational signatures of ccRCC vary between geographical regions	114
The impact of social determinants of health on acute kidney injury	111
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups	110
Informing clinical decision making during a pandemic — a call for better preparedness	106
The effects of sex hormone therapy on kidney function	104
Clonal haematopoiesis and AKI	101
20 years of Nature Reviews Nephrology	100
Increasing diversity and inclusion in nephrology clinical trials	96
Interferon blockade in lupus: effects on antiviral immunity	96
The roles of hyaluronan in kidney development, physiology and disease	94
Aquaporin water channels: roles beyond renal water handling	94
Menopause and chronic kidney disease	91
Design of a renal-sparing antifungal	89
Innovating dialysis through computational modelling of hollow-fibre haemodialysers	87
Benefits of actin cytoskeleton stabilization	87
Treatment of SLE with anti-CD19 CAR-T cells	85
Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure	84
Tertiary lymphoid organs contribute to kidney allograft rejection	81
Heat and health inequity: acting on determinants of health to promote heat justice	81
Environmental stewardship and health systems: Indigenous-centred reflections	80
Salt substitution: opportunities and challenges for nephrology	80
Identification of erythropoietin-producing cells	74
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)	74
From fat to filter: the effect of adipose tissue-derived signals on kidney function	73
Long-term health outcomes associated with hydration status	72
The role of complement in kidney disease	72
Neutrophils and NETs in kidney disease	71
Pathological mechanisms of kidney disease in ageing	70
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework	69
The evolving landscape of immune-mediated glomerular diseases	69
Reaping the rewards of mechanistic discovery in glomerular disease	69
A golden year of innovative kidney disease therapeutics	68
A label-free optical analysis for molecular nephrology	62
MSC therapy for diabetic kidney disease and nephrotic syndrome	61
Atmospheric stressors and kidney diseases	60
Network medicine: an approach to complex kidney disease phenotypes	60
Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges	58
A pathway of osmotic stress-induced necroptosis	58
Combination therapy for kidney disease in people with diabetes mellitus	57
Consequence of microvascular inflammation in transplantation	57
Ketogenic diet benefits in critically ill patients with sepsis	55
Transcatheter mitral valve repair in patients with CKD	54
Consequences of famine and malnourishment on kidney health	53
GalNAc-T14-associated defects in B cell homing in IgA nephropathy	50

Long COVID and the kidney	50
The cilia mechanosensation debate gets (bio)physical	50
Quality-oriented diet therapy for chronic kidney disease	49
PDGFRβ CAR T cells improve fibrosis in kidney disease models	47
Role of the cGAS–STING pathway in systemic and organ-specific diseases	44
Community power building to reduce inequities in access to health care	44
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney	43
Continuing kidney care in conflicts	43
Stem cell–kidney transplantation in Schimke immuno-osseous dysplasia	42
Mechanism of B cell survival in lupus nephritis	42
Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors	42
Dietary protection of proximal tubules in diabetes	42
Gene therapy in a model of nephrotic syndrome	41
Multifaceted innovations needed to advance transplant nephrology	40
Mannose as a driver of γδ T cell kidney infiltration	40
The kidney is a novel target of metformin	40
Born too soon: lifelong kidney risks and the importance of early intervention	39
Targeting IL-1Ra to attenuate fungal infection	38
Cardiovascular mortality increases with stage of cardiovascular–kidney–metabolic syndrome	38
Generation of self-assembling kidney progenitor assembloids	37
IL-6 signalling contributes to the pathogenesis of uraemic calciphylaxis	36
Steps forward in the treatment of IgA nephropathy	36
Epithelial cell states associated with kidney and allograft injury	36
Chronic cardiovascular–kidney disorder: a new conceptual framework	35
A guide to gene–disease relationships in nephrology	35
The genetics of hypertension	34
Metabolic alterations in hereditary and sporadic renal cell carcinoma	34
Role of necroptosis in kidney health and disease	33
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope	33
Fasting induces structural and functional changes in the peritoneal membrane	32
Derivation of collecting duct organoids	32
Strategies to achieve gender equity in nephrology	31
Insights into the impact of pregnancy on kidney disease	30
Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits	30
A guide to uraemic toxicity	30
Acute kidney injury in patients with burns	28
Renal nerves in physiology, pathophysiology and interoception	28
Leveraging data as a patient–scientist: frustrations and opportunities	27
The increasing burden of mild and moderate anaemia in CKD	27
Green nephrology: from evidence to action	26
The immunology of sepsis: translating new insights into clinical practice	26
Author Correction: Therapeutic advances in COVID-19	26
The impact of intrauterine growth restriction and prematurity on nephron endowment	26
From big data to smart decisions: artificial intelligence in kidney risk assessment	26
Fibroblast activation and heterogeneity in fibrotic disease	25
Author Correction: Regulatory T cells in autoimmune kidney diseases and transplantation	25
Insulin resistance and hyperinsulinaemia in kidney disease: mechanisms and metabolic effects	25
Experimental evidence for a pathogenic role of anti-PLA2R1 antibodies in membranous nephropathy	24
Crosstalk between glomeruli and tubules	23
CD38 — a new target in renal immune disease	23
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors	22
Digital determinants of health: opportunities and risks amidst health inequities	22
When access outpaces ethics: reflections on dialysis expansion and health system integrity	21
Switching off SOX9 for epithelial recovery after AKI	21
Impact of persistent conflict and destabilizing events on dialysis care	20
Hope for resistant hypertension through BrigHTN and PRECISION	20
Collagen formation, function and role in kidney disease	20
Nephrology and women’s health post-Roe v. Wade: we must do better	19
The impact of population ageing on the burden of chronic kidney disease	19
Improving the quality of pharmacoepidemiological studies using the target trial emulation framework	19
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup	19
Bridging the gap of referral to nephrology care	19
Indigenous kidney health outcomes will not improve without multilevel interventions	18
Kidney transplants: from antigen recognition to targeted therapy	18
A year of disruption and progress in kidney health policy	17
Deep learning applications in digital pathology	16
Podocyte-targeted therapies — progress and future directions	16
A novel gene therapy approach for nephropathic cystinosis	16
Pathogenic cellular and molecular mediators in lupus nephritis	15
The endothelium response to kidney injury	15
Application of spatial-omics to the classification of kidney biopsy samples in transplantation	15
Use of kidneys from SARS-CoV-2 infected donors	14
Role of perivascular cells in kidney homeostasis, inflammation, repair and fibrosis	14
Increased PD1 signalling in kidney ageing	14
Cellular senescence: the good, the bad and the unknown	14
mTORC1 under the control of CB1R	13
Lived experience and empathy: lessons learned as a nephrologist with kidney disease	13
P3H2 in glomerular basement membrane regulation	13
TRPM channels in health and disease	12
Trained immunity: from kidney failure to organ transplantation	12

New evidence of the impact of mitochondria on kidney health and disease	11
Progress towards solving the donor organ shortage	11
Important roles of mechanical force and hydraulic pressure in kidney function	10
Advances and challenges in kidney fibrosis therapeutics	10
Publisher Correction: Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	10
Vascular damage in systemic lupus erythematosus	10
New and emerging therapies for diabetic kidney disease	10
Gasdermins and pyroptosis in the kidney	10
Insights into glomerular function and disease pathogenesis	10
Inflammation and gut dysbiosis as drivers of CKD–MBD	9
Pharmacogenomics in the clinic	9
Clonal haematopoiesis, ageing and kidney disease	9
Incorporating dementia screening in the care of patients with kidney disease	9
Author Correction: Beyond state borders: transforming dialysis care for undocumented immigrants	9
Cystatin C and the misdiagnosis of CKD in older adults	9
Thiazides in kidney transplant recipients: skin in the game	9
Advances in CRISPR therapeutics	8
Advancing gender equity to improve kidney care for women: a patient perspective	8
Cell and gene therapy for kidney disease	8
Kidney health outcomes of hypertensive disorders of pregnancy	8
Electronic patient-reported outcomes in chronic kidney disease	8
Diuretics in patients with chronic kidney disease	8
Anti-nephrin autoantibodies: a paradigm shift in podocytopathies	8
ECM remodelling by ADAMTS12 in fibrosis	8
The genetics and pathogenesis of CAKUT	8
Advances in risk prediction and treatment strategies for CKM syndrome	8
Youth-onset type 2 diabetes mellitus: an urgent challenge	7
Progress in xenotransplantation: overcoming immune barriers	7
Synchronization in the renal microcirculation	7
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential	7
Patient involvement in nephrology research	7
The role of lysosomes in metabolic and autoimmune diseases	7
Disasters and kidney care: pitfalls and solutions	7
Chronic kidney disease and the global public health agenda: an international consensus	7
Remodelling by macula densa cells	6
Long-term lessons from EMPA-KIDNEY	6
The slit diaphragm has a conserved fishnet architecture	6
Post-translational modifications in kidney diseases and associated cardiovascular risk	6
A guide to studying 3D genome structure and dynamics in the kidney	6
Renoprotective effects of sparsentan: clinical trial evidence in IgA nephropathy and FSGS	6
‘Missing’ disease-causing variants in Alport syndrome	6
Drug repurposing for glomerular diseases: an underutilized resource	6
The pathogenesis of pre-eclampsia in kidney donors	6
The intelligent podocyte: sensing and responding to a complex microenvironment	6
Avenciguat reduces albuminuria in patients with chronic kidney disease	6
Including sexual orientation and gender identity data to advance nephrology care	6
New insights into kidney crosstalk with distant organs	5
Removal of small, asymptomatic kidney stones	5
A new pathway links iron sensing with histone demethylation and regulation of mTORC1 activity	5
Improving nephrology care for people with cognitive impairments and their caregivers	5
Diagnosis of cardiovascular disease in patients with chronic kidney disease	5
The catastrophic costs of chronic kidney disease	5
Amino acid metabolism in kidney health and disease	5
Sexual orientation and gender identity in organ and tissue donation and transplantation	5
Iron deficiency of kidney macrophages in CKD	5
The kidney stroma in development and disease	5
Graph neural networks for computational nephrology	5
Intersectionality as a lens for achieving kidney health justice	5
Paths to organ damage and risk factors in AKI	5
Targeting iron uptake to correct T cell dysfunction	5
A polygenic score predicts CKD across ancestries	5
UTX regulates accumulation of lipids via kidney serine	5
Inequities in kidney health and kidney care	5
From resolution to reality: advancing point-of-care diagnostics for kidney disease in low-resource settings	4
AngII autoantibodies after SARS-CoV-2 infection	4
Overcoming barriers to deliver high quality kidney care	4
Improving outcomes in kidney transplantation through advances in donor organ perfusion	4
Collagen IV in Gould syndrome and Alport syndrome	4
Interactive exploration of multimodal spatial data with FUSION	4
Cell–cell crosstalk in kidney health and disease	4
Leveraging lysine metabolism for renoprotection	4
Propagation of acute kidney injury	4
Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia	4
Benefits of CoQ10 supplementation in patients with SRNS due to primary CoQ10 deficiency	4
Sex differences in kidney metabolism and DKD	4
The roles of tertiary lymphoid structures in chronic diseases	4
NCKs are essential to podocyte–GBM interactions	4
Kidney benefits of SLGT2 inhibitors: evidence from clinical trials	4
Protein handling in kidney tubules	4
Macrophages clean out the tubules	4
Bridging structure and function: artificial intelligence-based modelling of kidney proteins	3
Spatial transcriptomics in health and disease	3
GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease	3
New AAV vector targets glomerular endothelial cells	3
Optimal patient care in advanced chronic kidney disease progressing to kidney failure	3
Reply to ‘Use of convalescent plasma in the treatment of COVID-19’	3
Managing RAAS inhibitor use in advanced CKD	3
A CAAR NK cell approach to eliminate pathogenic autoantibody-secreting cells	3
Artificial intelligence approaches to enable early detection of CKD	3
Potassium and the kidney	3
Harnessing plant thylakoids to restore cellular function in AKI	3
The pathogenesis of IgA nephropathy and implications for treatment	3
Insights into basement membrane complexity	3
Targeting perivascular S1P attenuates inflammation	3
The importance of sex and gender in basic and clinical research	3